Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Short-term Debt
Borrowings and the current portion of long-term debt due within one year.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Short-term Debt · Q4 FY2024 · quarter ended Mar 2025
Short-term debt falls 29.0% from a year ago
Short-term debt stood at $314.23K at the end of Q4 FY2024, down 29.0% from a year earlier.
Context
- Short-term debt amounted to 5.9% of total assets at the end of Q4 FY2024, down 3.2 pp from a year earlier.
- Short-term debt increased in 0 of the last 2 fiscal years.
- FY2024 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether short-term debt keeps falling in the next quarterly balance sheet after a -29.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Debt history
USD · from the balance sheet
- Latest · FY2024
- 314.23K USD
- Year-over-year change
- -29.0%
- 2-year CAGR
- -27.0%
| Period | Period end | Short-term Debt | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 314.23K | -29.0% |
| FY2023 | 2024-03-31 | 442.61K | -24.9% |
| FY2022 | 2023-03-31 | 589.66K | — |
Short-term Debt vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 short-term debt of $314.23K is the 6th highest of the 10 companies compared; the peer median is $974K.
- Its year-over-year change of -29.0% is the 2nd highest of 6, against a peer median of -55.9%.
- Short-term debt amounts to 5.9% of total assets for MCTA, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $209.74M | +343916.5% | +1213.2% | 33.8% | |
| Mar 2026 | $14.75M | -57.8% | +56.7% | 1.0% | |
| Mar 2026 | $7.4M | — | — | 4.4% | |
| Mar 2026 | $1.5M | — | — | 0.5% | |
| Mar 2026 | $974K | -42.3% | — | 0.2% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $314.23K | -29.0% | — | 5.9% |
| Feb 2026 | $138K | -55.9% | -23.5% | 0.1% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MCTA) | $974K | -55.9% | +56.7% | 0.2% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.